Disc Medicine Stock Analysis
IRON Stock | 52.24 0.99 1.86% |
Disc Medicine is overvalued with Real Value of 46.42 and Target Price of 93.55. The main objective of Disc Medicine stock analysis is to determine its intrinsic value, which is an estimate of what Disc Medicine is worth, separate from its market price. There are two main types of Disc Medicine's stock analysis: fundamental analysis and technical analysis.
The Disc Medicine stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Disc Medicine is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Disc Stock trading window is adjusted to America/New York timezone.
Disc |
Disc Stock Analysis Notes
About 79.0% of the company shares are owned by institutional investors. The book value of Disc Medicine was currently reported as 14.85. The company recorded a loss per share of 3.96. Disc Medicine had not issued any dividends in recent years. The entity had 1:30 split on the 30th of December 2022. To learn more about Disc Medicine call Esq JD at 617 674 9274 or check out https://www.discmedicine.com.Disc Medicine Investment Alerts
Disc Medicine generated a negative expected return over the last 90 days | |
Net Loss for the year was (109.36 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Disc Medicine generates negative cash flow from operations | |
Over 79.0% of the company shares are owned by institutional investors | |
Latest headline from kalkinemedia.com: Is Disc Medicine Gaining Institutional Confidence |
Disc Medicine Upcoming and Recent Events
Earnings reports are used by Disc Medicine to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
29th of March 2024 Upcoming Quarterly Report | View | |
20th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
29th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Disc Largest EPS Surprises
Earnings surprises can significantly impact Disc Medicine's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-11-10 | 2022-09-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2024-03-21 | 2023-12-31 | -0.78 | -0.9 | -0.12 | 15 | ||
2023-08-11 | 2023-06-30 | -0.86 | -0.74 | 0.12 | 13 |
Disc Medicine Environmental, Social, and Governance (ESG) Scores
Disc Medicine's ESG score is a quantitative measure that evaluates Disc Medicine's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Disc Medicine's operations that may have significant financial implications and affect Disc Medicine's stock price as well as guide investors towards more socially responsible investments.
Disc Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.84 B.Disc Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.19) | (0.20) | |
Return On Capital Employed | (0.24) | (0.25) | |
Return On Assets | (0.19) | (0.20) | |
Return On Equity | (0.25) | (0.24) |
Management Efficiency
Disc Medicine has return on total asset (ROA) of (0.1875) % which means that it has lost $0.1875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2773) %, meaning that it created substantial loss on money invested by shareholders. Disc Medicine's management efficiency ratios could be used to measure how well Disc Medicine manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of March 2025, Return On Tangible Assets is likely to drop to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.25. As of the 22nd of March 2025, Other Assets is likely to grow to about 217.3 K, while Total Assets are likely to drop about 281.5 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 17.79 | 25.67 | |
Tangible Book Value Per Share | 17.79 | 25.67 | |
Enterprise Value Over EBITDA | (11.76) | (11.17) | |
Price Book Value Ratio | 3.36 | 3.53 | |
Enterprise Value Multiple | (11.76) | (11.17) | |
Price Fair Value | 3.36 | 3.53 | |
Enterprise Value | 837.6 M | 879.5 M |
The management team at Disc Medicine has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Technical Drivers
As of the 22nd of March, Disc Medicine shows the Standard Deviation of 2.12, variance of 4.49, and Mean Deviation of 1.72. Disc Medicine technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Disc Medicine Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Disc Medicine middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Disc Medicine. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Disc Medicine Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Disc Medicine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Disc Medicine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Disc Medicine insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Disc Medicine Outstanding Bonds
Disc Medicine issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Disc Medicine uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Disc bonds can be classified according to their maturity, which is the date when Disc Medicine has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
US254687DD54 Corp BondUS254687DD54 | View | |
DIS 77 30 OCT 25 Corp BondUS254687DF03 | View | |
DISNEY WALT NEW Corp BondUS25468PCP99 | View | |
DISNEY WALT NEW Corp BondUS25468PCR55 | View | |
US254687DH68 Corp BondUS254687DH68 | View | |
DISNEY WALT NEW Corp BondUS25468PBW59 | View | |
WALT DISNEY CO Corp BondUS254687FL52 | View | |
WALT DISNEY CO Corp BondUS254687FM36 | View |
Disc Medicine Predictive Daily Indicators
Disc Medicine intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Disc Medicine stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 39090.55 | |||
Daily Balance Of Power | (0.51) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 53.04 | |||
Day Typical Price | 52.77 | |||
Price Action Indicator | (1.29) | |||
Period Momentum Indicator | (0.99) | |||
Relative Strength Index | 37.18 |
Disc Medicine Corporate Filings
18th of March 2025 Other Reports | ViewVerify | |
F3 | 25th of February 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
10K | 21st of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
31st of January 2025 Other Reports | ViewVerify | |
28th of January 2025 Other Reports | ViewVerify | |
8K | 23rd of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
19th of December 2024 Other Reports | ViewVerify | |
26th of November 2024 Other Reports | ViewVerify |
Disc Medicine Forecast Models
Disc Medicine's time-series forecasting models are one of many Disc Medicine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Disc Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Disc Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Disc Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Disc shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Disc Medicine. By using and applying Disc Stock analysis, traders can create a robust methodology for identifying Disc entry and exit points for their positions.
Last Reported | Projected for Next Year |
Current Disc Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Disc analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Disc analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
93.55 | Strong Buy | 11 | Odds |
Most Disc analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Disc stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Disc Medicine, talking to its executives and customers, or listening to Disc conference calls.
Disc Stock Analysis Indicators
Disc Medicine stock analysis indicators help investors evaluate how Disc Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Disc Medicine shares will generate the highest return on investment. By understating and applying Disc Medicine stock analysis, traders can identify Disc Medicine position entry and exit signals to maximize returns.
Begin Period Cash Flow | 360.6 M | |
Long Term Debt | 28.3 M | |
Common Stock Shares Outstanding | 29.9 M | |
Total Stockholder Equity | 443.6 M | |
Tax Provision | 355 K | |
Property Plant And Equipment Net | 2.3 M | |
Cash And Short Term Investments | 489.9 M | |
Cash | 192.4 M | |
Accounts Payable | 7.9 M | |
Net Debt | -162.4 M | |
50 Day M A | 55.645 | |
Total Current Liabilities | 23.3 M | |
Non Current Assets Total | 3.2 M | |
Non Currrent Assets Other | 838 K | |
Stock Based Compensation | 16.8 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.